Loading…
WGS
GeneDx Holdings Corp.
NASDAQ· Healthcare· Diagnostics & Research· CUSIP 81663L200
$67.14-2.61%Price as of Oct 23, 00:53 UTC · updated once a day, after the close
At a glance
GeneDx Holdings Corp. (WGS) is listed on NASDAQ and classified in Diagnostics & Research, part of the Healthcare sector. It is headquartered in Stamford, United States and has 1,300 employees. The company is worth $2B. Revenue was $427.54M in fiscal 2025, up 40.0% from the year before. It reported a net loss of $21.02M. The share price is 60.7% below its 52-week high of $170.87. 5 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Ken Griffin (Citadel Advisors), at $59.41M. In that quarter, 2 of them opened or added to the position. No open-market insider trades in it were filed over the last 30 days.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Key metrics
- Market cap
- $2B
- P/E
- —
- Forward P/E
- 56.0x
- P/B
- 8.2x
- Dividend yield
- 0.00%
- Payout
- —
- EPS
- -$3.54
- ROE
- -40.80%
- Profit margin
- -23.41%
- Revenue growth
- +11.40%
- Beta
- 1.97
- 52-week high
- $170.87
- 52-week low
- $32.21
History
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -71.1% over 5Y.
today you would have $238.86▼ -76.1%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 6 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Year-end price | $130.06 | $76.86 | $2.75 | $8.71 | $147.18 | $364.32 | |
| P/S | 3.0x | 8.9x | 7.1x | 0.4x | 0.9x | 5.1x | 0.0x |
| P/B | 2.8x | 12.4x | 8.8x | 0.3x | 0.8x | 2.8x | — |
| EPS | -$0.73 | -$1.94 |
Fair price, seven ways
Seven formulas applied to the reported numbers, each with its assumption next to the result. None of them predicts a price.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Cash flow
$9.71
Cash flow growing 5.0% a year for 10 years, discounted at 10%, then 2.5% forever.
Operating
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Dividends
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| SLSSELLAS Life Sciences Group, Inc. | $9.98 | — | 14.6x | 0.00% | -39.63% | $2.02B |
| BCRXBiocryst Pharmaceuticals Inc | $7.78 | — | — | 0.00% | — | $1.99B |
| XERSXeris Biopharma Holdings, Inc. | $10.86 | — | — | 0.00% | — | $1.98B |
| ZYMEZymeworks Inc. | $28.44 |
About the company
- 1,300
- Stamford, United States